3 in DGIM take home teaching awards
Another academic year is coming to end, which means it's time to recognize individuals who have exemplified excellence in teaching during the year. Three teaching awards were given out and we are proud to announce the recipients are all GIM faculty members!
Bosworth op-ed "Why Medication Adherence Needs To Be A National Priority"
On June 12, Forbes Pharma & Healthcare published an op-ed by DGIM's Dr. Hayden Bosworth entitled, "Why Medication Adherence Needs To Be A National Priority".
Zullig featured on cover of HemOnc Today magazine
DGIM's own Leah Zullig, PhD, was featured on the cover for a recent paper she wrote on the need for inclusion of minorities and other traditionally underrepresented groups in cancer clinical trials.
Boggan accepts associate program director role
Joel Boggan, MD, has accepted the position of Associate Program Director in the Duke Internal Medicine Residency Program, which will begin on July 1.
Van Houtven Promoted to Full Professor
We are proud to announce Courtney Van Houtven, PhD, has been promoted to Full Professor!
New advance care planning initiative at the DOC
The Duke Outpatient Clinic is kicking off a new program to help increase patient engagement in advance care planning (ACP), the patient process of speaking with loved ones and the medical team about what the care you'd like to receive if unable to speak for yourself
Duke GIM philanthropy: Care by your side
Duke GIM recieves two recent philanthropic gifts. Learn how they will help accelerate the division.
Faculty Spotlight: Juan Marcos Gonzalez
This past January Juan Marcos Gonzalez, PhD, joined the Duke Division of General Internal Medicine and the Duke Clinical Research Institute (DCRI).
Williams' Annals of IM opinion article
First published online April 4, 2017, at Annals.org, this "Ideas and Opinions" article with Dr. John Williams as co-author now appears in the May 16, 2017, issue of the Annals of Internal Medicine.
GIM at ISPOR Annual Meeting
Elected last year, Shelby Reed, PhD, Professor of Medicine (GIM), is taking the reigns in July as President of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).